- Home
- ATRA vs MATH Comparison
ATRA vs MATH Comparison
Compare ATRA & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- MATH
- Stock Information
- Founded
- ATRA 2012
- MATH 2015
- Country
- ATRA United States
- MATH Hong Kong
- Employees
- ATRA N/A
- MATH N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- MATH Finance/Investors Services
- Sector
- ATRA Health Care
- MATH Finance
- Exchange
- ATRA Nasdaq
- MATH Nasdaq
- Market Cap
- ATRA 67.9M
- MATH 60.8M
- IPO Year
- ATRA 2014
- MATH N/A
- Fundamental
- Price
- ATRA $12.29
- MATH $2.80
- Analyst Decision
- ATRA Strong Buy
- MATH
- Analyst Count
- ATRA 3
- MATH 0
- Target Price
- ATRA $21.00
- MATH N/A
- AVG Volume (30 Days)
- ATRA 65.3K
- MATH 228.9K
- Earning Date
- ATRA 08-11-2025
- MATH 07-30-2025
- Dividend Yield
- ATRA N/A
- MATH N/A
- EPS Growth
- ATRA N/A
- MATH N/A
- EPS
- ATRA 0.56
- MATH 0.41
- Revenue
- ATRA $188,667,000.00
- MATH $44,567,257.00
- Revenue This Year
- ATRA N/A
- MATH N/A
- Revenue Next Year
- ATRA N/A
- MATH N/A
- P/E Ratio
- ATRA $21.82
- MATH $6.83
- Revenue Growth
- ATRA 202.41
- MATH 165.86
- 52 Week Low
- ATRA $5.01
- MATH $0.80
- 52 Week High
- ATRA $18.71
- MATH $4.17
- Technical
- Relative Strength Index (RSI)
- ATRA 62.30
- MATH 42.18
- Support Level
- ATRA $10.32
- MATH $2.66
- Resistance Level
- ATRA $12.31
- MATH $3.13
- Average True Range (ATR)
- ATRA 0.90
- MATH 0.36
- MACD
- ATRA -0.04
- MATH -0.05
- Stochastic Oscillator
- ATRA 77.93
- MATH 10.03
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.